Further characterization of the fate of human monoclonal antibodies in rhesus monkeys.
We have shown previously that human monoclonal antibodies are not very immunogenic in rhesus monkeys, with only one monkey out of five mounting an anti-monoclonal antibody response. Two additional monkeys have been injected multiple times with much larger amounts of one human monoclonal antibody. No anti-antibody response has been detected in these monkeys. Structural changes that occur in the monoclonal antibodies over time in vivo have been investigated by Western Blots using anti-idiotypic antisera. Sodium dodecyl sulfate gel electrophoresis reveals that very little antibody has altered molecular weight. Isoelectric focusing patterns change more dramatically. Forms of the antibodies with lower isoelectric points appear in the serum. These forms have a similar in vivo half-life as the freshly prepared antibody. Very low pI forms of the monoclonal antibodies are not detected in the serum. Isoelectric focusing can be used to determine the in vivo or in vitro condition of a monoclonal antibody preparation. Finally, the monkey anti-human IgG that arose in the single monkey studied previously has been further characterized.
Ehrlich
P H
PH
Monoclonal Antibody Department, Sandoz Pharmaceuticals Corporation, East Hanover, NJ 07936.
Moustafa
Z A
ZA
Justice
J C
JC
Harfeldt
K E
KE
Ostberg
L
L
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000302:isolation & purification; D006207:Half-Life; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism; D007525:Isoelectric Focusing; D008253:Macaca mulatta; D008970:Molecular Weight
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D007136:Immunoglobulins